Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus vs Standard Tacrolimus in Kidney Transplant
NCT02432833Phase 4Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- May 2015
- Primary completion
- Jan 2017
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by Chiesi Farmaceutici S.p.A.. Started May 2015; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02432833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02432833.